Treatment of vestibular neuritis - PubMed (original) (raw)
Treatment of vestibular neuritis
Mark F Walker. Curr Treat Options Neurol. 2009 Jan.
Abstract
Vestibular neuritis is an acute peripheral vestibulopathy. It is thought to result from a reactivation of herpes simplex virus that affects the vestibular ganglion, vestibular nerve, labyrinth, or a combination of these. The symptoms are prolonged continuous vertigo, nausea and vomiting, and imbalance. In evaluating a patient with an acute vestibular syndrome, it is important not to miss a central cause, such as a brainstem or cerebellar stroke or hemorrhage, which could be life-threatening. Definitive central signs are not always present. Thus, any patient thought to have vestibular neuritis who has significant vascular risk factors should be evaluated for possible stroke. Most patients recover well from vestibular neuritis, even without treatment. Nonetheless, studies suggest that a course of oral steroids accelerates the recovery of vestibular function; whether steroids influence long-term outcome is less certain. Thus, until more data become available, it is reasonable to treat otherwise healthy individuals who present within 3 days of onset and to withhold steroids from those who are at higher risk of complications. Antiemetics and vestibular suppressants are useful acutely but should be withdrawn as soon as possible (preferably after the first several days), because their prolonged use may impede the process of central vestibular compensation. Early resumption of normal activity should be encouraged, to promote compensation. Directed vestibular rehabilitation therapy can further promote this process.
Similar articles
- Vestibular neuritis.
Jeong SH, Kim HJ, Kim JS. Jeong SH, et al. Semin Neurol. 2013 Jul;33(3):185-94. doi: 10.1055/s-0033-1354598. Epub 2013 Sep 21. Semin Neurol. 2013. PMID: 24057821 Review. - VOR gain by head impulse video-oculography differentiates acute vestibular neuritis from stroke.
Mantokoudis G, Tehrani AS, Wozniak A, Eibenberger K, Kattah JC, Guede CI, Zee DS, Newman-Toker DE. Mantokoudis G, et al. Otol Neurotol. 2015 Mar;36(3):457-65. doi: 10.1097/MAO.0000000000000638. Otol Neurotol. 2015. PMID: 25321888 - Pharmacological treatment of vertigo.
Hain TC, Uddin M. Hain TC, et al. CNS Drugs. 2003;17(2):85-100. doi: 10.2165/00023210-200317020-00002. CNS Drugs. 2003. PMID: 12521357 Review. - Vestibular neuritis in children and adolescents: Clinical features and recovery.
Brodsky JR, Cusick BA, Zhou G. Brodsky JR, et al. Int J Pediatr Otorhinolaryngol. 2016 Apr;83:104-8. doi: 10.1016/j.ijporl.2016.01.027. Epub 2016 Feb 1. Int J Pediatr Otorhinolaryngol. 2016. PMID: 26968063 - [Vestibular function features and prognosis of vestibular neuritis in children].
Liu B, Li B, Zhang L, Jiang SM, Chen M, Liu W, Liu HH, Zhang J. Liu B, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Dec 7;53(12):899-903. doi: 10.3760/cma.j.issn.1673-0860.2018.12.005. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018. PMID: 30585000 Chinese.
Cited by
- Virtual and augmented reality in the vestibular rehabilitation of peripheral vestibular disorders: systematic review and meta-analysis.
Heffernan A, Abdelmalek M, Nunez DA. Heffernan A, et al. Sci Rep. 2021 Sep 8;11(1):17843. doi: 10.1038/s41598-021-97370-9. Sci Rep. 2021. PMID: 34497323 Free PMC article. - Breaking a dogma: acute anti-inflammatory treatment alters both post-lesional functional recovery and endogenous adaptive plasticity mechanisms in a rodent model of acute peripheral vestibulopathy.
El Mahmoudi N, Rastoldo G, Marouane E, Péricat D, Watabe I, Tonetto A, Hautefort C, Chabbert C, Sargolini F, Tighilet B. El Mahmoudi N, et al. J Neuroinflammation. 2021 Aug 21;18(1):183. doi: 10.1186/s12974-021-02222-y. J Neuroinflammation. 2021. PMID: 34419105 Free PMC article. - COVID-19-Induced Vestibular Neuritis, Hemi-Facial Spasms and Raynaud's Phenomenon: A Case Report.
Vanaparthy R, Malayala SV, Balla M. Vanaparthy R, et al. Cureus. 2020 Nov 28;12(11):e11752. doi: 10.7759/cureus.11752. Cureus. 2020. PMID: 33403182 Free PMC article. - Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.
Petremann M, Gueguen C, Delgado Betancourt V, Wersinger E, Dyhrfjeld-Johnsen J. Petremann M, et al. Br J Pharmacol. 2020 Feb;177(3):623-633. doi: 10.1111/bph.14803. Epub 2019 Aug 28. Br J Pharmacol. 2020. PMID: 31347148 Free PMC article. - Management of peripheral vertigo with antihistamines: New options on the horizon.
Dyhrfjeld-Johnsen J, Attali P. Dyhrfjeld-Johnsen J, et al. Br J Clin Pharmacol. 2019 Oct;85(10):2255-2263. doi: 10.1111/bcp.14046. Epub 2019 Jul 22. Br J Clin Pharmacol. 2019. PMID: 31269270 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources